BSE: TORNTPHARM - Torrent Pharmaceuticals Limited

Yield per half year: -11.41%
Dividend yield: +1.48%

Torrent Pharmaceuticals Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
3/10
52.33 45.74 14.4% 44.7 +17.06%
P/S 8.21 5.12 60.16%
P/BV 12.64 6.3 100.65%
P/FCF 23.19 168.72 -86.26%
Ev/Ebitda 19.65 13.54 45.14%
Ev/S 8.5 4.77 78.29%
Ev/FCF 31.69 163.7 -80.64%
E/P 0.0252 0.0451 -44.14%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
27.33 20.29 34.74% 28.98 -5.69%
ROE 25.38 17.11 48.29%
ROA 11.02 10.34 6.58%
ROIC 19.66 10.89 80.6%
ROS 15.68 11.98 30.87%
ROCE 0 4.26 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
8/10
1.36 1.22 11.95% 1.67 -18.23%
Nеt Debt/Ebitda 1.07 1.06 1.52%
Debt/Ratio 0.2614 0.1307 100.02%
Debt/Equity 0.7623 0.5488 38.9%
Debt/Net Income 2.38 3.19 -25.54%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
3.7/10
1.48 11.92 -87.59% 1.51 -2.28%
Number of years of dividend growth 0 1.26 -100%
DSI 0.8571 0.8503 0.8034%
Average dividend growth 11.51 -63.65 -118.08%
Average percentage for 5 years 1.51 11.6 -86.94%
Average percentage for payments 49.59 30.57 62.2%
Difference from average difference in sector -10.44

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
35.76 80.84 -55.76%
Growth impulse Ebitda in 5 years 71.8 45.31 58.46%
Growth impulse Net Income in 5 years 61.64 131.41 -53.09%
Growth impulse FCF in 5 years 187.61 76.02 146.79%
Growth impulse EPS in 5 years 61.6 286.48 -78.5%
IP Score
6.21/10

Similar companies

Apollo Hospitals Enterprise Limited

Alkem Laboratories Limited

Abbott India Limited

Cipla Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription